Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction

  • Briones, Ana|||0000-0001-8218-5579
  • Hernanz, Raquel
  • Garcia Redondo, Ana B.|||0000-0002-5815-3320
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Val-Blasco, Almudena
  • Alonso, María Jesús|||0000-0003-4912-1121
  • Salaices Sanchez, Mercedes|||0000-0003-3323-1692
Excessive local inflammation is a common mechanism in many cardiovascular diseases (CVDs) such as hypertension, atherosclerosis and aortic aneurysms. In endothelial cells, inflammatory cytokines such as interferons, tumour necrosis factor alpha or interleukins increase oxidative stress and contractile prostanoids and the expression of adhesion molecules that reduce nitric oxide (NO) availability and bind leucocytes, thereby impairing endothelial function. Despite this evidence, anti-inflammatory therapies are not yet indicated for the treatment of most CVD. Resolution of inflammation is mediated by a family of specialized pro-resolving mediators (SPMs) that act on cognate G protein-coupled receptors to limit immune cell infiltration and initiate tissue repair. SPMs, generated from omega-3 and omega-6 polyunsaturated fatty acids, belong to four major families: lipoxins, resolvins, protectins and maresins. SPM receptors are expressed in immune and vascular cells where they regulate important processes such as phagocytosis and polarization, production of cytokines, NO and prostacyclin, and modulation of smooth muscle cell phenotype. Growing evidence in animal models demonstrates that activation of SPM receptors can protect vascular function and structure and provide beneficial effects in various CVD. We will review recent advances in the role of inflammation and SPMs in vascular (dys)function in hypertension, atherosclerosis, and aortic aneurysms.
e-cienciaDatos, Repositorio de Datos del Consorcio Madroño
Research data Set de datos (Dataset)

Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: Role of perivascular mesenteric innervation

  • Méndez Albiñana, Pablo
  • Cros-Brunsó, Laia
  • Rodrigues Díez, Raquel
  • Rodríguez Rodríguez, Pilar
  • Santamaría Solís, Luis Vicente
  • Muñoz-Labrador, Ana
  • Requena, Teresa
  • Casaní, Laura
  • Caballero, Francisco Félix
  • Prieto Nieto, Maria Isabel
  • Villamiel, Mar
  • Blanco Rivero, Javier
<p>Effect of synbiotic supplementation on the body alterations in a rat model of liver colestasis.</p> <p>This dataset is supplementary material for the paper: "Synbiotic administration improves systemic and vascular alterations in rats with experimental microsurgical extrahepatic cholestasis: role of perivascular mesenteric innervation". It contains 6 tables and 7 figures.</p> <ul> <p>Background</p> <p>Liver cholestasis is marked by bile acid accumulation in the liver, along with renal issues, portal hypertension, and altered circulation. Previous studies suggest that synbiotics may improve systemic and hemodynamic conditions in liver diseases.</p> <p>Objective</p> <p>This study investigated the effects of a commercial synbiotic on gut microbiota, liver and kidney function, and vascular changes in a cholestatic rat model, focusing on nerve functions in the superior mesenteric arteries.</p> </p>Methodology</p> <p>Adult Wistar rats were divided into three groups: Sham-operated, Cholestatic, and Cholestatic with synbiotic supplementation for 3 weeks. Liver colestasis was induced by surgical techniques. Blood pressure was measured using tail-cuff method.Liver and renal structure were determined using histological techniques (hematoxilin-eosin tinction). Liver and renal parameters in serum were measured using spectrophotometrical techniques. Short chain fatty acids were determined through liquid chromatography. Gene expression in kidney and fecal simples were determined by qRT-PCR. Vasomotor responses in superior mesenteric artery were determined by vascular reactivity techniques (organ bath).Neurotransmitter and endotoxin releases were measured using enzymeinmunoassay and fluorescence techniques. Protein expression was measured using western blot.</p> </ul>